Cas no 75371-78-7 ((R)-3-methylpent-4-enoic acid)
(R)-3-methylpent-4-enoic acid Chemical and Physical Properties
Names and Identifiers
-
- 4-Pentenoic acid, 3-methyl-, (R)-
- (R)-3-methylpent-4-enoic acid
-
- Inchi: 1S/C6H10O2/c1-3-5(2)4-6(7)8/h3,5H,1,4H2,2H3,(H,7,8)/t5-/m0/s1
- InChI Key: QNPZXLANENFTFK-YFKPBYRVSA-N
- SMILES: OC(C[C@H](C=C)C)=O
Computed Properties
- Exact Mass: 114.0681
Experimental Properties
- PSA: 37.3
(R)-3-methylpent-4-enoic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | R990150-1mg |
(R)-3-methylpent-4-enoic acid |
75371-78-7 | 1mg |
$ 50.00 | 2022-06-03 | ||
| TRC | R990150-2mg |
(R)-3-methylpent-4-enoic acid |
75371-78-7 | 2mg |
$ 70.00 | 2022-06-03 | ||
| TRC | R990150-10mg |
(R)-3-methylpent-4-enoic acid |
75371-78-7 | 10mg |
$ 295.00 | 2022-06-03 | ||
| Enamine | EN300-364913-0.05g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 0.05g |
$659.0 | 2025-03-18 | |
| Enamine | EN300-364913-0.1g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 0.1g |
$859.0 | 2025-03-18 | |
| Enamine | EN300-364913-0.25g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 0.25g |
$1225.0 | 2025-03-18 | |
| Enamine | EN300-364913-0.5g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 0.5g |
$1931.0 | 2025-03-18 | |
| Enamine | EN300-364913-1.0g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 1.0g |
$2475.0 | 2025-03-18 | |
| Enamine | EN300-364913-2.5g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 2.5g |
$4851.0 | 2025-03-18 | |
| Enamine | EN300-364913-5.0g |
(3R)-3-methylpent-4-enoic acid |
75371-78-7 | 73.0% | 5.0g |
$7178.0 | 2025-03-18 |
(R)-3-methylpent-4-enoic acid Related Literature
-
S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
Additional information on (R)-3-methylpent-4-enoic acid
Introduction to 4-Pentenoic acid, 3-methyl-, (R)- (CAS No. 75371-78-7)
4-Pentenoic acid, 3-methyl-, (R)-, identified by its Chemical Abstracts Service (CAS) number 75371-78-7, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This enantiomer, specifically the (R)-configuration, possesses unique structural and functional properties that make it a valuable candidate for various applications in drug discovery and synthetic chemistry.
The molecular structure of 4-Pentenoic acid, 3-methyl-, (R)- consists of a pentenone backbone with a methyl group at the third carbon position and a carboxylic acid functional group at the fourth carbon. The (R)-configuration refers to the stereochemical arrangement of the molecule, which influences its interactions with biological targets. This stereochemistry is critical in pharmaceutical applications, as enantiomers can exhibit markedly different biological activities despite having identical chemical compositions.
In recent years, there has been growing interest in the therapeutic potential of 4-Pentenoic acid, 3-methyl-, (R)- due to its ability to modulate various biological pathways. Research has demonstrated that this compound can interact with specific enzymes and receptors, making it a promising scaffold for developing novel therapeutic agents. For instance, studies have shown that derivatives of this compound may exhibit anti-inflammatory and analgesic properties, which could be beneficial in treating chronic pain conditions and inflammatory disorders.
The synthesis of 4-Pentenoic acid, 3-methyl-, (R)- presents unique challenges due to its stereospecific nature. Advanced synthetic methodologies, such as asymmetric hydrogenation and enzymatic resolution, have been employed to achieve high enantiomeric purity. These techniques are essential for ensuring that the final product retains its desired biological activity. The development of efficient synthetic routes has enabled researchers to produce larger quantities of this compound, facilitating further exploration of its potential applications.
One of the most intriguing aspects of 4-Pentenoic acid, 3-methyl-, (R)- is its role as a building block in the synthesis of more complex molecules. Its reactive double bond and carboxylic acid group make it a versatile intermediate for constructing heterocyclic compounds and other pharmacologically active entities. Researchers have leveraged these properties to develop novel drug candidates targeting various diseases, including cancer and neurodegenerative disorders.
Recent advancements in computational chemistry have also contributed to the understanding of 4-Pentenoic acid, 3-methyl-, (R)-'s interactions with biological systems. Molecular modeling studies have provided insights into how this compound binds to its targets at the atomic level, offering valuable information for drug design and optimization. These computational approaches complement experimental techniques, enabling a more holistic understanding of the compound's mechanism of action.
The pharmaceutical industry has taken note of the potential of 4-Pentenoic acid, 3-methyl-, (R)- and is actively exploring its applications in drug development. Several preclinical studies have demonstrated promising results in animal models, suggesting that this compound may have therapeutic efficacy in humans. While further research is needed to confirm these findings and address any potential side effects, the early successes are encouraging for future clinical trials.
Beyond its pharmaceutical applications, 4-Pentenoic acid, 3-methyl-, (R)- also finds utility in chemical research as a reference standard and intermediate for synthesizing other compounds. Its well-characterized structure and stereochemistry make it an ideal candidate for teaching and training purposes in academic institutions. Additionally, its role in developing new synthetic methodologies contributes to the broader advancement of organic chemistry.
The environmental impact of producing and using 4-Pentenoic acid, 3-methyl-, (R)- is another area of consideration. Efforts are being made to optimize synthetic routes for greater efficiency and sustainability. Green chemistry principles are being applied to minimize waste and reduce energy consumption during production. These initiatives align with global efforts to promote environmentally friendly practices in chemical manufacturing.
In conclusion,4-Pentenoic acid, 3-methyl-, (R)- (CAS No. 75371-78-7) is a multifaceted compound with significant potential in pharmaceutical research and chemical synthesis. Its unique structural features and stereochemical properties make it a valuable tool for developing new drugs and understanding biological mechanisms. As research continues to uncover new applications for this compound,4-Pentenoic acid, (R)-configuration, and related derivatives are likely to play an increasingly important role in advancing medical science.
75371-78-7 ((R)-3-methylpent-4-enoic acid) Related Products
- 1879-03-4(3-Methylpent-4-enoic acid)
- 7796-73-8(3,3-dimethyl-4-pentenoic acid)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)